Although you may have been vaccinated against meningococcal disease strain C, you are still vulnerable to other vaccine-preventable strains including A, B, Y, and W-135.
is a quadrivalent meningococcal vaccine that can help protect you against 4 IMD strains: A, C, Y, and W-135.
can be used in people who have already been vaccinated against strain C, broadening coverage to include protection against strains A, Y, and W-135, and boosting protection against strain C. Persons aged 2 to 55 years should be given a single dose
. Persons with underlying medical conditions, such as HIV, asplenia, or antibody deficiencies, should consult with their doctor regarding the appropriate dosing schedule.
has over 10 years of real-world experience and 75 million doses distributed worldwide.
Ask your healthcare provider how MENACTRA®
can help protect you from IMD.
If you would like to learn more about IMD, you can also visit the Public Health Agency of Canada website